BELLRING BRANDS ALERT: Bragar Eagel & Squire, P.C. is Investigating BellRing Brands Inc. on Behalf of BellRing Brands Stockholders and Encourages Investors to Contact the Firm

(NYSE:BRBR), NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against BellRing Brands Inc. (“BellRing Brands” or the “Company”) (NYSE: BRBR) on behalf of BellRing Brands stockholders. Our investigation concerns whether BellRing Brands has violated the federal securities laws and/or […]

China Airlines and The New Terminal One Announce Strategic Partnership, Transforming Customer Experience in New York City

China Airlines (CAL), a Taiwan-based carrier, will begin operations at The New Terminal One at New York John F. Kennedy International Airport in 2026, launching an elevated travel experience for its valued customers. The long-term partnership between China Airlines and the New Terminal One will support the carrier's ambition to expand its network in North

First Kaiser Permanente babies born at HCA HealthONE Rose

New arrivals mark major step in Kaiser Permanente's expanded relationships with HCA HealthONE and CommonSpirit Health KaiserPermanente welcomed its first baby at HCA HealthONE Rose – a baby girl born at 12:27 p.m. on July 7, 2025. She weighed 7 pounds, 3 ounces and measured 18.5 inches long. She was the first baby born to

Rosen Law Firm Encourages TechTarget, Inc. Investors to Inquire About Securities Class Action Investigation – TTGT

https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TechTarget, Inc. (NASDAQ: TTGT) resulting from allegations that TechTarget may have issued materially misleading business information to the investing public. So What: If you purchased TechTarget securities you may be entitled to compensation

Fosun International’s FTSE Russell ESG Rating Outperforms Global Industry Average, Marks Fourth Consecutive Year in FTSE4Good Index

On 8 July 2025, the world's leading index company,FTSE Russell, recently announced the latest Environmental, Social and Governance (ESG) rating results forFosun International Limited (HKEX stock code: 00656) (“Fosun International”). In 2025, Fosun International's FTSE Russell ESG rating was upgraded to 3.9, consistently outperforming the global industry average (2.6) and the nationalaverage (2.0), while maintaining

IOVA Deadline: IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) securities between May 9, 2024 and May 8, 2025, both dates inclusive (the “Class Period”), of the important July 14, 2025 lead plaintiff deadline. https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg So What: If you purchased Iovance securities during the Class Period you may

Fosun International’s FTSE Russell ESG Rating Outperforms Global Industry Average, Marks Fourth Consecutive Year in FTSE4Good Index

On 8 July 2025, the world's leading index company,FTSE Russell, recently announced the latest Environmental, Social and Governance (ESG) rating results forFosun International Limited (HKEX stock code: 00656) (“Fosun International”). In 2025, Fosun International's FTSE Russell ESG rating was upgraded to 3.9, consistently outperforming the global industry average (2.6) and the nationalaverage (2.0), while maintaining

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages 3D Systems Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – DDD

(NYSE:DDD), NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of 3D Systems Corporation (NYSE: DDD) between August 13, 2024 and May 12, 2025, both dates inclusive (the “Class Period”), of the important August 12, 2025 lead plaintiff deadline. SO WHAT: If

SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit

https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline. So What: If you purchased Sarepta Therapeutics securities during the Class

Scroll to Top